Literature DB >> 2257212

Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx.

F Esteban1, A Concha, M Delgado, M Pérez-Ayala, F Ruiz-Cabello, F Garrido.   

Abstract

A series of 60 primary laryngeal and hypopharyngeal tumours, 24 lymph node metastases and normal tissue were evaluated in frozen sections for the expression of MHC class I antigens, using monoclonal antibodies and the APAAP technique. We found 13 tumours presenting total HLA-ABC loss, five with selective loss of HLA-A antigens and one with absence of HLA-B antigens. These losses were statistically associated with clinical and pathological parameters, such as T stage, degree of differentiation, scores according to the Jakobsson and Glanz grading systems and degree of leukocytic infiltration. Our results lead us to the following conclusions: (a) HLA class I losses were found in a group of tumours showing greater aggressiveness and worse prognosis; (b) these alterations in expression were not associated with an increased metastatic potential. Thus, the absence of HLA molecules in laryngeal tumours is related to greater local aggressiveness, and the loss of class I antigens seems to constitute an adaptive tumour mechanism to avoid the different anatomical and immunological barriers within the larynx.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2257212      PMCID: PMC1971557          DOI: 10.1038/bjc.1990.437

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  22 in total

1.  Mutation selection and the natural history of cancer.

Authors:  J Cairns
Journal:  Nature       Date:  1975-05-15       Impact factor: 49.962

2.  The incidence of cervical lymph node metastases from epidermoid carcinoma of the larynx and their relationship to certain characteristics of the primary tumor. A study based on the clinical and pathological findings for 96 patients treated by primary en bloc laryngectomy and radical neck dissection.

Authors:  M H MCGAVRAN; W C BAUER; J H OGURA
Journal:  Cancer       Date:  1961 Jan-Feb       Impact factor: 6.860

3.  Cytotoxic T cells recognize fragments of the influenza nucleoprotein.

Authors:  A R Townsend; F M Gotch; J Davey
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

Review 4.  Evolution of tumours and the impact of molecular oncology.

Authors:  G Klein; E Klein
Journal:  Nature       Date:  1985 May 16-22       Impact factor: 49.962

5.  Prognostic value of vascular invasion in squamous cell carcinoma of the head and neck.

Authors:  S Poleksic; H J Kalwaic
Journal:  Plast Reconstr Surg       Date:  1978-02       Impact factor: 4.730

6.  Phenotypic dynamics of tumor progression in human malignant melanoma.

Authors:  E B Bröcker; L Suter; J Brüggen; D J Ruiter; E Macher; C Sorg
Journal:  Int J Cancer       Date:  1985-07-15       Impact factor: 7.396

7.  Striking paucity of HLA-A, B, C and beta 2-microglobulin on human neuroblastoma cell lines.

Authors:  L A Lampson; C A Fisher; J P Whelan
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

8.  Prognostic factors in laryngeal carcinoma. A multifactorial study of 416 cases.

Authors:  E Pera; A Moreno; L Galindo
Journal:  Cancer       Date:  1986-08-15       Impact factor: 6.860

9.  Prognostic value of histopathologic parameters in squamous cell carcinoma of the oropharynx.

Authors:  J D Crissman; W Y Liu; J L Gluckman; G Cummings
Journal:  Cancer       Date:  1984-12-15       Impact factor: 6.860

10.  Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer.

Authors:  A Doyle; W J Martin; K Funa; A Gazdar; D Carney; S E Martin; I Linnoila; F Cuttitta; J Mulshine; P Bunn
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance.

Authors:  Robert L Ferris; Jennifer L Hunt; Soldano Ferrone
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

2.  Major histocompatibility complex class I expression in human tonsillar and laryngeal epithelium.

Authors:  C G L Hobbs; L E N Rees; R S Heyderman; M A Birchall; M Bailey
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

Review 3.  Biologic markers, cellular differentiation, and metastatic head and neck cancer.

Authors:  S P Schantz
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

4.  Expression of MHC class I and class II antigens in primary breast carcinomas and synchronous nodal metastases.

Authors:  A Maiorana; A M Cesinaro; R A Fano; G Collina
Journal:  Clin Exp Metastasis       Date:  1995-01       Impact factor: 5.150

5.  Expression of HLA-ABC, HLA-DR and intercellular adhesion molecule-1 in oesophageal carcinoma.

Authors:  J C Rockett; S J Darnton; J Crocker; H R Matthews; A G Morris
Journal:  J Clin Pathol       Date:  1995-06       Impact factor: 3.411

6.  Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human Lymphomas.

Authors:  Devin Dersh; James D Phelan; Megan E Gumina; Boya Wang; Jesse H Arbuckle; Jaroslav Holly; Rigel J Kishton; Tovah E Markowitz; Mina O Seedhom; Nathan Fridlyand; George W Wright; Da Wei Huang; Michele Ceribelli; Craig J Thomas; Justin B Lack; Nicholas P Restifo; Thomas M Kristie; Louis M Staudt; Jonathan W Yewdell
Journal:  Immunity       Date:  2020-12-02       Impact factor: 31.745

Review 7.  Do telomerase antagonists represent a novel anti-cancer strategy?

Authors:  E K Parkinson
Journal:  Br J Cancer       Date:  1996-01       Impact factor: 7.640

8.  MHC class I antigens and tumour-infiltrating leucocytes in laryngeal cancer: long-term follow-up.

Authors:  F Esteban; M Redondo; M Delgado; F Garrido; F Ruiz-Cabello
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

9.  Comprehensive genomic characterization of head and neck squamous cell carcinomas.

Authors: 
Journal:  Nature       Date:  2015-01-29       Impact factor: 49.962

Review 10.  Novel Immunotherapeutic Approaches for Head and Neck Squamous Cell Carcinoma.

Authors:  Darrin V Bann; Daniel G Deschler; Neerav Goyal
Journal:  Cancers (Basel)       Date:  2016-09-22       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.